Longevity & AgingResearch PaperOpen Access

Scientists Decode How Cells Add Fatty Acids to Proteins During Translation

New research reveals the molecular machinery that attaches myristic acid to proteins as they're made, opening drug targets.

Saturday, April 18, 2026 0 views
Published in Mol Cell
Molecular machinery at a ribosome exit tunnel showing protein enzymes NMT1 and NAC complex attaching fatty acids to emerging protein chains

Summary

Researchers have uncovered how human cells attach myristic acid—a 14-carbon fatty acid—to newly synthesized proteins through a process called N-myristoylation. This modification is crucial for protein function and cellular localization. The study reveals that the enzyme NMT1 works with a protein complex called NAC to efficiently target specific proteins during translation. Understanding this mechanism could lead to better cancer and antiviral treatments, as NMTs are important drug targets currently in clinical trials.

Detailed Summary

This groundbreaking study solves a long-standing puzzle in cell biology: how cells precisely attach fatty acids to newly made proteins. N-myristoylation—the addition of myristic acid to protein N-termini—affects over 500 human proteins and is essential for their proper function and cellular localization.

Using advanced cryo-electron microscopy and biochemical techniques, researchers mapped exactly how the enzyme NMT1 interacts with ribosomes during protein synthesis. They discovered that NMT1 works in concert with the nascent polypeptide-associated complex (NAC) and exchanges positions with methionine aminopeptidase (METAP1) at the ribosome's exit tunnel in a carefully choreographed sequence.

The key finding is that NMT1 binding is sequence-selective and specifically triggered when METAP1 removes the initial methionine residue, exposing the glycine that becomes the target for myristoylation. This timing mechanism ensures that only appropriate proteins receive the fatty acid modification while preventing competing enzymes from interfering.

These insights have significant therapeutic implications. NMT enzymes are proven drug targets for cancer and viral infections, with several compounds currently in clinical trials. Understanding the precise molecular mechanism could enable development of more specific inhibitors with fewer side effects. The research also reveals why certain genetic mutations affecting NAC or NMT function lead to disease, providing new avenues for therapeutic intervention.

Key Findings

  • NMT1 exchanges with METAP1 at ribosome exit tunnels in a coordinated sequence
  • NAC protein complex recruits NMT1 via flexible C-terminal arm interactions
  • Methionine removal specifically triggers NMT1 binding to nascent proteins
  • NMT1 makes direct contact with ribosomal protein uL23 for positioning
  • Disrupting NAC-NMT1 interactions severely impairs protein myristoylation

Methodology

Researchers used cryo-electron microscopy at 2.8 Å resolution, FRET-based binding assays, and photo-crosslinking to map protein interactions. They studied ribosome-nascent chain complexes with Src protein substrates and validated findings in human cell culture.

Study Limitations

Study focused primarily on NMT1 and Src substrates. The flexible N-terminal domain of NMT1 wasn't fully resolved structurally. Long-term effects of NAC or NMT disruption in human health require further investigation.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.